DRG Instruments GmbH
Booth number: 3.D27
drg-diagnostics.de
About us
DRG – More than 50 Years of Innovative Diagnostics
The DRG group is a leading manufacturer of ELISAs for clinical diagnostics and research with distributors in over 110 countries. DRG is also the manufacturer of the DRG:HYBRiD-XL®, a fully automated analyzer for immunoassays and clinical chemistry. Founded in 1970, DRG International, Inc. provides a complete range of products and services to the diagnostic and research communities.
DRG Instruments GmbH, was founded in 1973 by DRG International, Inc. (NJ, USA) and is based in Marburg, Germany. In 2021 DRG International, Inc. was acquired by BioCheck Inc. (CA, USA). Together with the DRG group, BioCheck’s goal is to provide timely information so that treatment can be initiated earlier and efficacy analyzed sooner to better the long-term outcomes.
DRG is an ISO 13485:2016 certified company and operates in compliance with FDA 21 CFR 820 Quality System Regulation.
Address
Frauenbergstr. 18
35039 Marburg
Germany
Phone: +49 6421 17000
Products & Services
DRG is specialized in the development and production of innovative immunoassays, for routine and research applications, in the fields of diabetes diagnosis, endocrinology, prenatal/neonatal supervision, thyroid function, iron metabolism, saliva diagnostics, infectious diseases and many more. DRG is also the manufacturer of the DRG:HYBRiD-XL, a fully automated analyzer for immunoassays and clinical chemistry. Recently DRG has launched a new product group for the fully automatic determination of antibiotic TDMs for DRG:HYBRiD-XL. Furthermore, DRG/BioCheck has announced the agreement to distribute MedCaptain CLIA device ImmuF6 and it’s associated menu of reagent assays.DRG:HYBRiD-XL
Single Test Cartridge System for Immunoassay and Clinical Chemistry Tests
